Cheil Bio Co

Cheil Bio Co Depreciation & Amortization

Delisted·Feb 25, 2026

The Depreciation & Amortization of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 97.98 M KRW. In the previous year, Depreciation & Amortization was 96.04 M KRW — a change of 2.02% (higher).

Depreciation & Amortization

97.98 MKRW

YoY

2.02%

Last updated:

Depreciation & Amortization of Cheil Bio Co is 2024 97.98 M KRW. Depreciation & Amortization of Cheil Bio Co was 2023 96.04 M KRW. It decreases by 2.02% higher compared to the previous year.

The Cheil Bio Co Depreciation & Amortization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Depreciation & Amortization
Date
Depreciation & Amortization
Jan 1, 2017
110.00 M KRW
Jan 1, 2018
116.00 M KRW
Jan 1, 2019
158.00 M KRW
Jan 1, 2020
136.00 M KRW
Jan 1, 2021
120.99 M KRW
Jan 1, 2022
99.99 M KRW
Jan 1, 2023
96.04 M KRW
Jan 1, 2024
97.98 M KRW
The Cheil Bio Co Depreciation & Amortization history
YEARDepreciation & AmortizationYoY
97.98 MKRW+2.02%
96.04 MKRW-3.95%
99.99 MKRW-17.36%
120.99 MKRW-11.04%
136.00 MKRW-13.92%
158.00 MKRW+36.21%
116.00 MKRW+5.45%
110.00 MKRW+4.76%
105.00 MKRW+26.51%
83.00 MKRW+59.62%
52.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Depreciation & Amortization of Cheil Bio Co is 97.98 M KRW in 2024.

Depreciation & Amortization of Cheil Bio Co changed from 96.04 M KRW to 97.98 M KRW, representing a 2.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Depreciation & Amortization Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Depreciation & Amortization represents the allocation of the cost of tangible and intangible assets over their useful lives.

Depreciation & Amortization's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Depreciation & Amortization's Cheil Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cheil Bio Co

All Key Metrics — Cheil Bio Co